Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Cytomegalovirus Infection

Free Subscription Articles published in Transplantation Retrieve available abstracts of 27 articles: HTML format

Single Articles

April 2024
1. PENNINGTON KM, Martin MJ, Murad MH, Sanborn D, et al
   Risk Factors for Early Fungal Disease in Solid Organ Transplant Recipients: A Systematic Review and Meta-analysis.
   Transplantation. 2024;108:970-984.
   PubMed     Abstract available
   
   
   January 2024
2. ROBERTS MB, Kotton CN
   Conversion to mTOR Inhibitor to Reduce the Incidence of Cytomegalovirus Recurrence in Kidney Transplant Recipients Receiving Preemptive Treatment: A Prospective, Randomized Trial.
   Transplantation. 2024 Jan 26. doi: 10.1097/TP.0000000000004908.
   PubMed    
   
   
   
3. ROBERTS MB, Kotton CN
   Letermovir Prophylaxis After Kidney Transplantation: Another Tool but Not a Revolution Yet.
   Transplantation. 2024;108:7-9.
   PubMed    
   
   
   December 2023
4. QIU Y, Zhang Y, Teng M, Cheng S, et al
   Efficacy, Safety, and Cost-effectiveness Analysis of Antiviral Agents for Cytomegalovirus Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplantation Recipients.
   Transplantation. 2023 Dec 5. doi: 10.1097/TP.0000000000004856.
   PubMed     Abstract available
   
   
   November 2023
5. REUSING JO JR, Agena F, Kotton CN, Campana G, et al
   QuantiFERON-CMV as a Predictor of CMV Events During Preemptive Therapy in CMV-seropositive Kidney Transplant Recipients.
   Transplantation. 2023 Nov 22. doi: 10.1097/TP.0000000000004870.
   PubMed     Abstract available
   
   
   October 2023
6. STEWART AG, Kotton CN
   What's New: Updates on Cytomegalovirus in Solid Organ Transplantation.
   Transplantation. 2023 Oct 30. doi: 10.1097/TP.0000000000004855.
   PubMed     Abstract available
   
   
   August 2023
7. TONIATO DE REZENDE FRESCHI J, Cristelli MP, Viana LA, Ficher KN, et al
   A Head-to-head Comparison of De Novo Sirolimus or Everolimus Plus Reduced-dose Tacrolimus in Kidney Transplant Recipients: A Prospective and Randomized Trial.
   Transplantation. 2023 Aug 1. doi: 10.1097/TP.0000000000004749.
   PubMed     Abstract available
   
   
   May 2023
8. BLOM KB, Birkeland GK, Midtvedt K, Jenssen TG, et al
   Cytomegalovirus High-risk Kidney Transplant Recipients Show No Difference in Long-term Outcomes Following Preemptive Versus Prophylactic Management.
   Transplantation. 2023 May 26. doi: 10.1097/TP.0000000000004615.
   PubMed     Abstract available
   
   
   
9. KOTTON CN
   The Best Method for CMV Prevention in High-risk Kidney Transplant Recipients? Either, per National Norwegian Transplant Database: Commentary on Blom et al, Cytomegalovirus High-risk Kidney Transplant Recipients Show No Difference in Long-term Outcomes
   Transplantation. 2023 May 22. doi: 10.1097/TP.0000000000004616.
   PubMed    
   
   
   April 2023
10. VIANA LA, Cristelli MP, Basso G, Santos DW, et al
    Conversion to mTOR Inhibitor to Reduce the Incidence of Cytomegalovirus Recurrence in Kidney Transplant Recipients Receiving Preemptive Treatment: A Prospective, Randomized Trial.
    Transplantation. 2023 Apr 13. doi: 10.1097/TP.0000000000004559.
    PubMed     Abstract available
    
    
    
11. PIERROTTI LC, Clemente WT
    New Perspectives in Cytomegalovirus After Transplant: The Role of Immunosuppressant Management.
    Transplantation. 2023 Apr 13. doi: 10.1097/TP.0000000000004560.
    PubMed    
    
    
    March 2023
12. MOSSAD SB
    Changes in Donor and Recipient Demographic Characteristics Over Time Explain the Increasing Prevalence of the High-risk Cytomegalovirus Donor-positive/Recipient-negative Serostatus in Solid Organ Transplant Recipients.
    Transplantation. 2023;107:e82.
    PubMed    
    
    
    
13. HIGDON LE, Tan JC, Maltzman JS
    Infection, Rejection, and the Connection.
    Transplantation. 2023;107:584-595.
    PubMed     Abstract available
    
    
    October 2022
14. SCHOEBERL AK, Zuckermann A, Kaider A, Aliabadi-Zuckermann A, et al
    Absolute Lymphocyte Count as a Marker for Cytomegalovirus Infection After Heart Transplantation.
    Transplantation. 2022 Oct 13. pii: 00007890-990000000-00197.
    PubMed     Abstract available
    
    
    September 2022
15. IMLAY H, Wagener MM, Vutien P, Perkins J, et al
    Increasing Proportion of High-risk Cytomegalovirus Donor-Positive/Recipient-Negative Serostatus in Solid Organ Transplant Recipients.
    Transplantation. 2022 Sep 29. pii: 00007890-990000000-00175.
    PubMed     Abstract available
    
    
    June 2022
16. 
    Cytomegalovirus Infection Downregulates Vitamin D Receptor in Patients Undergoing Hematopoietic Stem Cell Transplantation: Erratum.
    Transplantation. 2022;106:e324.
    PubMed    
    
    
    April 2022
17. KAUKE-NAVARRO M, Panayi AC, Formica R, Marty F, et al
    Cytomegalovirus-related Complications and Management in Facial Vascularized Composite Allotransplantation: An International Multicenter Retrospective Cohort Study.
    Transplantation. 2022 Apr 6. pii: 00007890-990000000-00012.
    PubMed     Abstract available
    
    
    March 2022
18. PEGHIN M, Hirsch HH
    CARVs, CLAD and CMV: A Call for Heightened Awareness in Lung Transplant Recipients.
    Transplantation. 2022 Mar 18. pii: 00007890-900000000-95049.
    PubMed    
    
    
    September 2021
19. HEIM C, Muller PP, Tandler R, Cherikh WS, et al
    Cytomegalovirus Donor Seropositivity Negatively Affects Survival After Heart Transplantation.
    Transplantation. 2021 Sep 23. pii: 00007890-900000000-95151.
    PubMed     Abstract available
    
    
    July 2021
20. AXELROD D, Chang SH, Lentine KL, Schnitzler MA, et al
    The Clinical and Economic Benefit of CMV Matching in Kidney Transplant: A Decision Analysis.
    Transplantation. 2021 Jul 6. pii: 00007890-900000000-95204.
    PubMed     Abstract available
    
    
    
21. L S, I A, N R, J W, et al
    P-74: Change in CMV Infection Rates Over Time at a UK Transplant Centre.
    Transplantation. 2021;105.
    PubMed    
    
    
    June 2021
22. LIU XB, Liu H, Liu J, Cheung AKL, et al
    Cytomegalovirus Latency Exacerbated small-for-size Liver Graft Injury through Activation of CCL19/CCR7 in Hepatic Stellate Cells.
    Transplantation. 2021 Jun 2. doi: 10.1097/TP.0000000000003846.
    PubMed     Abstract available
    
    
    March 2021
23. DAVID E, Zhu M, Bennett BC, Cheng D, et al
    Undernutrition and Hypoleptinemia Modulate Alloimmunity and CMV-specific Viral Immunity in Transplantation.
    Transplantation. 2021 Mar 10. pii: 00007890-900000000-95315.
    PubMed     Abstract available
    
    
    December 2020
24. SINGH N, Winston DJ, Razonable RR, Lyon GM, et al
    Association of HHV-6 With Outcomes in CMV-Seronegative Liver Transplant Recipients With CMV-Seropositive Donors Receiving Preemptive Antiviral Therapy.
    Transplantation. 2020 Dec 29. pii: 00007890-900000000-95428.
    PubMed     Abstract available
    
    
    November 2020
25. COOK CH
    Cytomegalovirus: Another Source of Antibody Mediated Graft Injury?
    Transplantation. 2020 Nov 18. doi: 10.1097/TP.0000000000003549.
    PubMed    
    
    
    
26. SAUNDERS U, Li M, Boddeda SR, Maher S, et al
    Murine Cytomegalovirus-Induced Complement-fixing Antibodies Deposit in Murine Renal Allografts During Acute Rejection.
    Transplantation. 2020 Nov 18. doi: 10.1097/TP.0000000000003548.
    PubMed     Abstract available
    
    
    February 2020
27. KOTTON CN
    A Fine Balance: Using Letermovir for Salvage Antiviral Treatment While Preserving Efficacy.
    Transplantation. 2020;104:240-241.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Cytomegalovirus Infection is free of charge.